B. Winblad, P. Amouyel, S. Andrieu, C. Ballard, C. Brayne et al., Defeating Alzheimer's disease and other dementias: a priority for European science and society, Lancet Neurol, vol.15, issue.5, pp.455-532, 2016.

A. Viswanathan, W. A. Rocca, and C. Tzourio, Vascular risk factors and dementia: how to move forward? Neurology, vol.72, pp.368-74, 2009.

S. Norton, F. E. Matthews, D. E. Barnes, K. Yaffe, and C. Brayne, Potential for primary prevention of Alzheimer's disease: an analysis of population-based data, Lancet Neurol, vol.13, issue.8, pp.788-94, 2014.

R. F. De-bruijn, M. J. Bos, M. L. Portegies, A. Hofman, O. H. Franco et al., The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study, BMC Med, vol.13, p.132, 2015.

C. Raffaitin, H. Gin, J. P. Empana, C. Helmer, C. Berr et al., Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study, Diabetes Care, vol.32, issue.1, pp.169-74, 2009.

R. A. Whitmer, S. Sidney, J. Selby, S. C. Johnston, and K. Yaffe, Midlife cardiovascular risk factors and risk of dementia in late life, Neurology, vol.64, issue.2, pp.277-81, 2005.

M. Kivipelto, E. L. Helkala, M. P. Laakso, T. Hanninen, M. Hallikainen et al., Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease, Ann Intern Med, vol.137, issue.3, p.12160362, 2002.

M. Kivipelto, T. Ngandu, L. Fratiglioni, M. Viitanen, I. Kareholt et al., Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease, Arch Neurol, vol.62, issue.10, pp.1556-60, 2005.

I. Notkola, R. Sulkava, J. Pekkanen, T. Erkinjuntti, C. Ehnholm et al., Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease, Neuroepidemiology, vol.17, issue.1, 1998.

A. Solomon, M. Kivipelto, B. Wolozin, J. Zhou, and R. A. Whitmer, Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later, Dement Geriatr Cogn Disord, vol.28, issue.1, pp.75-80, 2009.

C. Reitz, M. Tang, J. Luchsinger, and R. Mayeux, Relation of plasma lipids to Alzheimer disease and vascular dementia, Arch Neurol, vol.61, issue.5, pp.705-719, 2004.

T. Yoshitake, Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto et al., Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study, Neurology, vol.45, issue.6, p.7783883, 1995.

M. A. Beydoun, L. L. Beason-held, M. H. Kitner-triolo, H. A. Beydoun, L. Ferrucci et al., Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment, J Epidemiol Community Health, vol.65, issue.11, pp.949-57, 2011.

G. Li, J. B. Shofer, W. A. Kukull, E. R. Peskind, D. W. Tsuang et al., Serum cholesterol and risk of Alzheimer disease: a community-based cohort study, Neurology, vol.65, issue.7, 2005.

S. Kalmijn, D. Foley, L. White, C. M. Burchfiel, J. D. Curb et al., Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study, Arterioscler Thromb Vasc Biol, vol.20, issue.10, p.11031212, 2000.

M. Muller, M. X. Tang, N. Schupf, J. J. Manly, R. Mayeux et al., Metabolic syndrome and dementia risk in a multiethnic elderly cohort, Dement Geriatr Cogn Disord, vol.24, issue.3, pp.185-92, 2007.

V. Solfrizzi, E. Scafato, C. Capurso, D. 'introno, A. Colacicco et al., Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing, J Neurol Neurosurg Psychiatry, vol.81, issue.4, pp.433-473, 2010.

K. M. Hayden, P. P. Zandi, C. G. Lyketsos, A. S. Khachaturian, L. A. Bastian et al., Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study, Alzheimer Dis Assoc Disord, vol.20, issue.2, pp.93-100, 2006.

M. M. Mielke, P. P. Zandi, M. Sjogren, D. Gustafson, S. Ostling et al., High total cholesterol levels in late life associated with a reduced risk of dementia, Neurology, vol.64, issue.10, pp.1689-95, 2005.

C. Reitz, M. X. Tang, N. Schupf, J. J. Manly, R. Mayeux et al., Association of higher levels of highdensity lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease, Arch Neurol, vol.67, issue.12, pp.1491-1498, 2010.

B. H. Strand, E. M. Langballe, V. Hjellvik, M. Handal, Ø. Naess et al., Midlife vascular risk factors and their association with dementia deaths: results from a Norwegian prospective study followed up for 35 years, J Neurol Sci, vol.324, issue.1, pp.124-154, 2013.

A. Alonso, D. R. Jacobs, A. Menotti, A. Nissinen, A. Dontas et al., Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study, J Neurol Sci, vol.280, issue.1, pp.79-83, 2009.

S. Schilling, C. Tzourio, C. Dufouil, Y. Zhu, C. Berr et al., Plasma lipids and cerebral small vessel disease, Neurology, vol.83, issue.20, p.25320101, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01196098

D. Carmelli, G. E. Swan, T. Reed, P. A. Wolf, B. L. Miller et al., Midlife cardiovascular risk factors and brain morphology in identical older male twins, Neurology, vol.52, issue.6, p.10214731, 1999.

K. Park, N. Yasuda, S. Toyonaga, S. M. Yamada, H. Nakabayashi et al., Significant association between leukoaraiosis and metabolic syndrome in healthy subjects, Neurology, vol.69, issue.10, p.17538033, 2007.

S. Debette, A. Beiser, C. Decarli, R. Au, J. J. Himali et al., Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study, Stroke, vol.41, issue.4, pp.600-606, 2010.

. 3c-study-group, Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population, Neuroepidemiology, vol.22, issue.6, p.14598854, 2003.

R. Stewart, L. R. White, Q. L. Xue, and L. J. Launer, Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study, Arch Neurol, vol.64, issue.1, p.17210816, 2007.

H. Amieva, H. Jacqmin-gadda, J. M. Orgogozo, L. Carret, N. Helmer et al., The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, vol.128, pp.1093-101, 2005.

H. Amieva, L. Goff, M. Millet, X. Orgogozo, J. M. Peres et al., Prodromal Alzheimer's disease: successive emergence of the clinical symptoms, Ann Neurol, vol.64, issue.5, pp.492-500, 2008.

H. Jacqmin-gadda, C. Fabrigoule, D. Commenges, L. Letenneur, and J. F. Dartigues, A cognitive screening battery for dementia in the elderly, J Clin Epidemiol, vol.53, issue.10, p.11027929, 2000.

, Diagnostic and statistical manual of mental disorders, 2000.

S. Katz, A. B. Ford, R. W. Moskowitz, B. A. Jackson, and M. W. Jaffe, Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function, JAMA, vol.185, p.14044222, 1963.

M. P. Lawton, Scales to measure competence in everyday activities, Psychopharmacol Bull, vol.24, issue.4, p.3074322, 1988.

I. Rosow and N. Breslau, A Guttman health scale for the aged, J Gerontol, vol.21, issue.4, p.5918309, 1966.

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, issue.7, p.6610841, 1984.

G. C. Roman, T. K. Tatemichi, T. Erkinjuntti, J. L. Cummings, J. C. Masdeu et al., Vascular dementia: diagnostic criteria for research studies, Report of the NINDS-AIREN International Workshop. Neurology, vol.43, issue.2, p.8094895, 1993.

W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, vol.18, issue.6, p.4337382, 1972.

C. Dufouil, F. Richard, N. Fievet, J. F. Dartigues, K. Ritchie et al., APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study, Neurology, vol.64, issue.9, pp.1531-1539, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00175952

A. C. Thiebaut and J. Benichou, Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study, Stat Med, vol.23, issue.24, pp.3803-3823, 2004.

J. Li and J. L. , Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix, Heredity (Edinb), vol.95, issue.3, pp.221-228, 2005.

J. M. Zissimopoulos, D. Barthold, R. D. Brinton, and G. Joyce, Sex and race differences in the association between statin use and the incidence of Alzheimer disease, JAMA Neurol, vol.74, issue.2, pp.225-257, 2017.

K. Leffondre, K. J. Jager, J. Boucquemont, V. S. Stel, and G. Heinze, Representation of exposures in regression analysis and interpretation of regression coefficients: basic concepts and pitfalls, Nephrol Dial Transplant, vol.29, issue.10, pp.1806-1820, 2014.

D. Y. Lin, L. Wei, and Y. Z. , Checking the Cox model with cumulative sums of Martingale-based residuals, Biometrika, vol.80, issue.3, pp.557-72, 1993.

M. L. Ancelin, E. Ripoche, A. M. Dupuy, P. Barberger-gateau, S. Auriacombe et al., Sex differences in the associations between lipid levels and incident dementia, J Alzheimers Dis, vol.34, issue.2, pp.519-547, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00782575

Z. S. Tan, S. Seshadri, A. Beiser, P. W. Wilson, D. P. Kiel et al., Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study, Arch Int Med, vol.163, issue.9, pp.1053-1060, 2003.

P. Forti, N. Pisacane, E. Rietti, A. Lucicesare, V. Olivelli et al., Metabolic syndrome and risk of dementia in older adults, J Am Geriatr Soc, vol.58, issue.3, p.20398117, 2010.

M. W. Warren, L. S. Hynan, and M. F. Weiner, Lipids and adipokines as risk factors for Alzheimer's disease, J Alzheimers Dis, vol.29, issue.1, pp.151-158, 2012.

M. Bonarek, P. Barberger-gateau, L. Letenneur, V. Deschamps, A. Iron et al., Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study, Neuroepidemiology, vol.19, issue.3, pp.141-149, 2000.

C. L. Satizabal, A. S. Beiser, V. Chouraki, G. Chene, C. Dufouil et al., Incidence of dementia over three decades in the Framingham Heart Study, N Engl J Med, vol.374, issue.6, pp.523-555, 2016.

C. R. Jack, D. S. Knopman, W. J. Jagust, R. C. Petersen, M. W. Weiner et al., Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, Lancet Neurol, vol.12, issue.2, pp.207-223, 2013.

S. E. Vermeer, N. D. Prins, T. Den-heijer, A. Hofman, P. J. Koudstaal et al., Silent brain infarcts and the risk of dementia and cognitive decline, N Engl J Med, vol.348, issue.13, pp.1215-1237, 2003.

P. B. Verghese, J. M. Castellano, and D. M. Holtzman, Apolipoprotein E in Alzheimer's disease and other neurological disorders, Lancet Neurol, vol.10, issue.3, pp.241-52, 2011.

A. S. Henderson, S. Easteal, A. F. Jorm, A. J. Mackinnon, A. E. Korten et al., Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample, Lancet, vol.346, issue.8987, 1995.

J. C. Lambert, C. A. Ibrahim-verbaas, D. Harold, A. C. Naj, R. Sims et al., Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nat Genet, vol.45, issue.12, p.24162737, 2013.

S. D. Ostergaard, S. Mukherjee, S. J. Sharp, P. Proitsi, L. A. Lotta et al., Associations between potentially modifiable risk factors and Alzheimer disease: a Mendelian randomization study, PLoS Med, vol.12, issue.6, p.1001841, 2015.

B. Mcguinness, D. Craig, R. Bullock, and P. Passmore, Statins for the prevention of dementia, Cochrane Database Syst Rev, vol.1, p.3160, 2016.

S. Debette, Vascular risk factors and cognitive disorders, Rev Neurol (Paris), vol.169, issue.10, pp.757-64, 2013.

S. Trompet, P. Van-vliet, A. J. De-craen, J. Jolles, B. M. Buckley et al., Pravastatin and cognitive function in the elderly. Results of the PROSPER study, J Neurol, vol.257, issue.1, pp.85-90, 2010.

, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial, Lancet, vol.360, issue.9326, pp.7-22, 2002.

C. Baigent, L. Blackwell, J. Emberson, L. E. Holland, C. Reith et al., Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, vol.376, issue.9753, pp.1670-81, 2010.

M. H. Davidson, E. A. Stein, C. A. Dujovne, D. B. Hunninghake, S. R. Weiss et al., The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day, Am J Cardiol, vol.79, issue.1, p.9024733, 1997.

M. C. Power, J. Weuve, A. R. Sharrett, D. Blacker, and R. F. Gottesman, Statins, cognition, and dementiasystematic review and methodological commentary, Nat Rev Neurol, vol.11, issue.4, pp.220-229, 2015.

M. D. Haag, A. Hofman, P. J. Koudstaal, B. H. Stricker, and M. M. Breteler, Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study, J Neurol Neurosurg Psychiatry, vol.80, issue.1, pp.13-20, 2009.

B. Wolozin, S. W. Wang, N. C. Li, A. Lee, T. A. Lee et al., Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease, BMC Med, vol.5, p.17640385, 2007.

C. Helmer, K. Peres, L. Letenneur, L. M. Guttierez-robledo, H. Ramaroson et al., Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity, Dement Geriatr Cogn Disord, vol.22, issue.1, pp.87-94, 2006.

S. Debette and S. Seshadri, Vascular risk factors and dementia revisited, J Neurol Neurosurg Psychiatry, vol.80, issue.11, 2009.

J. Weuve, C. Proust-lima, M. C. Power, A. L. Gross, S. M. Hofer et al., Guidelines for reporting methodological challenges and evaluating potential bias in dementia research, Alzheimers Dement, vol.11, issue.9, pp.1098-109, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01288885